@sun_in_winter12 Glycolysis-enhancing α1-adrenergic antagonists modify cognitive symptoms related to Parkinson’s disease https://t.co/5QqreU2MVQ "PD patients newly started on terazosin, alfuzosin, or doxazosin had a lower hazard of being diagnosed with …
RT @narayananlab: Nice to see independent replication of our findings that glycolysis-enhancing drugs can slow the diagnosis of PD: https:/…
Nice to see independent replication of our findings that glycolysis-enhancing drugs can slow the diagnosis of PD: https://t.co/3tr8m4T9MZ Replicating: https://t.co/6ihY9YdWQz https://t.co/YiWXtCfkTI https://t.co/YJYwrkWQR9
"Terazosin is an α1-adrenergic receptor antagonist that enhances glycolysis and increases cellular ATP by binding to the enzyme phosphoglycerate kinase 1 (PGK1)." https://t.co/mmTbPCBEOn